DGI Clinical

DGI Clinical

Empowering personalized symptom management for dementia care and treatment decisions.

Founded 2000 11-50 employees Seed Biotechnology, Health Care

DGI Clinical is a biotechnology startup with a focus on healthcare, aiming to empower personalized symptom management for dementia care and treatment decisions. Founded in 2000 and based in Halifax, Nova Scotia, the company is led by Dr. Kenneth Rockwood, a renowned dementia specialist and geriatrician. The startup's flagship product, DementiaGuide.com, serves as an interactive disease management tool, providing personalized information about symptoms as they progress over time. DGI Clinical's emphasis on addressing the significant social and economic costs associated with dementia is particularly noteworthy. The absence of a cure for dementia underscores the critical need for improved care and treatment options, making the company's innovative health management technologies timely and essential. The launch of DementiaGuide.com in 2006 further attests to the startup's commitment to tackling this pressing issue. The platform offers an interactive tool, SymptomGuideTM, designed for caregivers and healthcare professionals. It allows for the identification and management of dementia symptoms on an individualized basis, distinguishing itself from static information sources. The dynamic approach provided by the tool enables users to create detailed symptom profiles and monitor changes over time, generating easy-to-read reports crucial for diagnostic, treatment, and disease management decisions. Notably, SymptomGuideTM also supports the aggregation of data for analysis and customized reporting for pharmaceutical companies, offering valuable insights into drug performance during clinical trials and post-marketing. This demonstrates the startup's adaptability and relevance to the broader healthcare ecosystem. The Seed Round investment at 01 June 2001 secured from Innovacorp signals early investor confidence in DGI Clinical's potential impact and the value of its solutions within the biotechnology and health care industries.

Funding Stage	Amount	Investors	Lead Investors	Date
Seed Round	Undisclosed	1	Innovacorp	01 Jun 2001

Funding Stage

Amount

Investors

Lead Investors

Date

Seed Round

Undisclosed

Innovacorp

01 Jun 2001

FAQ About DGI Clinical

Empowering personalized symptom management for dementia care and treatment decisions.

DGI Clinical was founded in 2000.

DGI Clinical operates in Biotechnology and Health Care. Its work centres on Dementia Management, Symptom Tracking, Personalized Care and Clinical Data Analysis.

DGI Clinical has approximately 11-50 employees.

DGI Clinical has completed 1 funding round. The latest funding stage is Seed.

Top alternatives and competitors to DGI Clinical include Medtep, VivoSense, Inc., COMS Interactive, Heartflow, RAMP.medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

DGI Clinical and Medtep are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About DGI Clinical

Funding Rounds & Investors (1)

DGI Clinical Alternatives & Competitors

FAQ About DGI Clinical